# THOTH

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thoth

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.thoth-health.com
- Latest round: Series C (Jul 30, 2021)
- Investors on record: 16

## About

Established in 2016 and based in Suzhou, China, THOTH is a medical technology company that focuses on the research and development of flexible wearable medical devices and the application of medical big data artificial intelligence technology. The company main involved in the field of dynamic ECG (Electrocardiogram) monitoring, body temperature monitoring and fetal ECG (Electrocardiogram) monitoring and obtained 30 patents. In 2017, the company has launched a wearable body temperature detector and a fetal ECG (Electrocardiogram) monitor. The company has completed 7 rounds of funding until 2021.

The company's main product is self-develop Wearable ECG (Electrocardiogram) sensor that are similar to a Band-Aid. Besides, the company's provides clinical-level medical services for customer.

## Funding rounds

- Series C, Jul 30, 2021 — Orchid Asia Group, Oriental Fortune Capital, CMB International Asset Management, Hangzhou Envision Investment, Shanghai Jianyi Private Equity Fund Management, China Growth Capital, HFI Industry Fund Management, Innovation Dark Horse Fund
- Series B, Jun 11, 2020 — Harmony Venture, Innovation Dark Horse Fund
- Series B, Jan 8, 2020 — Hangzhou Envision Investment, Renhe Capital, Fengyi Yuanda Fund
- Series B, Apr 23, 2018 — Hongtai Aplus, CapHill Investments, Suzhou Industrial Park Jinhe Venture Angel Charity Foundation
- Series A, Aug 30, 2016 — Prosperico Ventures, Rays Venture Capital

## Investors

- Prosperico Ventures (https://capitalatlas.ai/funds/prosperico-ventures) — Series A
- Rays Venture Capital (https://capitalatlas.ai/funds/rays-venture-capital) — Series A
- Hongtai Aplus (https://capitalatlas.ai/funds/hongtai-aplus) — Series B
- CapHill Investments — Series B
- Suzhou Industrial Park Jinhe Venture Angel Charity Foundation — Series B
- Hangzhou Envision Investment (https://capitalatlas.ai/funds/hangzhou-envision-investment) — Series B, Series C
- Renhe Capital (https://capitalatlas.ai/funds/renhe-capital) — Series B
- Fengyi Yuanda Fund (https://capitalatlas.ai/funds/fengyi-yuanda-fund) — Series B
- Harmony Venture (https://capitalatlas.ai/funds/harmony-venture) — Series B
- Innovation Dark Horse Fund (https://capitalatlas.ai/funds/innovation-dark-horse-fund) — Series B, Series C
- Orchid Asia Group (https://capitalatlas.ai/funds/orchid-asia-group) — Series C
- Oriental Fortune Capital (https://capitalatlas.ai/funds/oriental-fortune-capital) — Series C
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series C
- Shanghai Jianyi Private Equity Fund Management (https://capitalatlas.ai/funds/shanghai-jianyi-private-equity-fund-management) — Series C
- China Growth Capital (https://capitalatlas.ai/funds/china-growth-capital) — Series C
- HFI Industry Fund Management (https://capitalatlas.ai/funds/hfi-industry-fund-management) — Series C